Nurix Therapeutics(NRIX.US) Officer Sells US$119.84K in Common Stock

$Nurix Therapeutics(NRIX.US)$ Officer Ring Christine sold 5,760 shares of common stock on Jul 1, 2024 at an average price of $20.805 for a total value of $119.84K.Source: Announcement What is statemen

Futu News07:17

Form 144 | Nurix Therapeutics(NRIX.US) Officer Proposes to Sell 120.21K in Common Stocks

SEC FILLINGS DISCLOSED/ Jul 1, $Nurix Therapeutics(NRIX.US)$ Officer CHRISTINE RING intends to sell 5,760 shares of its common stock on Jul 1, with a total market value of approximately $120.21K. CH

Futu News04:40

Expert Outlook: Nurix Therapeutics Through The Eyes Of 14 Analysts

In the last three months, 14 analysts have published ratings on Nurix Therapeutics (NASDAQ:NRIX), offering a diverse range of perspectives from bullish to bearish.The table below summarizes their rece

BenzingaJun 27 23:00

Nurix Therapeutics Is Maintained at Outperform by RBC Capital

Nurix Therapeutics Is Maintained at Outperform by RBC Capital

Dow JonesJun 27 22:40

RBC Capital Maintains Outperform on Nurix Therapeutics, Raises Price Target to $26

RBC Capital analyst Gregory Renza maintains Nurix Therapeutics (NASDAQ:NRIX) with a Outperform and raises the price target from $23 to $26.

BenzingaJun 27 22:30

Nurix Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/27/2024 24.02% RBC Capital $23 → $26 Maintains Outperform 06/18/2024 24.02% HC Wainwright & Co. $19 → $

BenzingaJun 27 22:29